NO922422L - MATERIAL WITH ADHERENT BONDED CELLS, AND PROCEDURES FOR PRODUCING VIRUS / VIRUS ANTIGENS - Google Patents
MATERIAL WITH ADHERENT BONDED CELLS, AND PROCEDURES FOR PRODUCING VIRUS / VIRUS ANTIGENSInfo
- Publication number
- NO922422L NO922422L NO92922422A NO922422A NO922422L NO 922422 L NO922422 L NO 922422L NO 92922422 A NO92922422 A NO 92922422A NO 922422 A NO922422 A NO 922422A NO 922422 L NO922422 L NO 922422L
- Authority
- NO
- Norway
- Prior art keywords
- virus
- cells
- antigens
- bound
- fsme
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title abstract 7
- 239000000427 antigen Substances 0.000 title abstract 5
- 102000036639 antigens Human genes 0.000 title abstract 5
- 108091007433 antigens Proteins 0.000 title abstract 5
- 230000001464 adherent effect Effects 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 210000004027 cell Anatomy 0.000 abstract 4
- 239000000758 substrate Substances 0.000 abstract 3
- 241000710771 Tick-borne encephalitis virus Species 0.000 abstract 2
- 230000001419 dependent effect Effects 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 210000004102 animal cell Anatomy 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 206010014599 encephalitis Diseases 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 230000002779 inactivation Effects 0.000 abstract 1
- 230000002101 lytic effect Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 201000011475 meningoencephalitis Diseases 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 210000003501 vero cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A matrix or substrate bears adherently bound human or animal cells infected with a virus. It has been shown that surface dependent cells useful for virus multiplication remain adherently bound to a matrix even when infected with a virus, produce virus antigens over a relatively long period of time and release them in the culture medium. In order to produce early Summer meningo-encephalitis (FSME) virus antigens by cultivating the FSME virus in cell cultures, a surface dependent permanent cell line, preferably the vero-cell line ATTC CCL 81, is inoculated with the FSME virus and the cells are bound to substrates and kept in a non lytic serum free system in conditions that ensure cellular growth, so that antigens are produced. The antigen-containing medium is then separated from the substrate bound cells and processed in a known manner by concentration, inactivation and purification until a galenically acceptable composition is obtained.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT2928/89A AT393356B (en) | 1989-12-22 | 1989-12-22 | METHOD FOR PRODUCING TBE VIRUS ANTIGES |
| PCT/AT1990/000128 WO1991009935A1 (en) | 1989-12-22 | 1990-12-21 | Matrix with adherently bound cells and process for producing viruses/virus antigens |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO922422D0 NO922422D0 (en) | 1992-06-19 |
| NO922422L true NO922422L (en) | 1992-08-17 |
| NO310305B1 NO310305B1 (en) | 2001-06-18 |
Family
ID=3542524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19922422A NO310305B1 (en) | 1989-12-22 | 1992-06-19 | Matrix with adherently bound cells, as well as the method of producing late-summer meningoencephalitis (FSME) virus antigen |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0506714B1 (en) |
| JP (1) | JP2633391B2 (en) |
| AT (2) | AT393356B (en) |
| CA (1) | CA2071954C (en) |
| CZ (1) | CZ281804B6 (en) |
| DE (1) | DE59007659D1 (en) |
| DK (1) | DK0506714T3 (en) |
| ES (1) | ES2067916T3 (en) |
| FI (1) | FI98377C (en) |
| HR (1) | HRP921354A2 (en) |
| HU (1) | HU213886B (en) |
| NO (1) | NO310305B1 (en) |
| RU (1) | RU2082757C1 (en) |
| SK (1) | SK659090A3 (en) |
| WO (1) | WO1991009935A1 (en) |
| YU (1) | YU242390A (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3158157B2 (en) * | 1994-11-10 | 2001-04-23 | バクスター・アクチエンゲゼルシャフト | Biopharmaceutical production in protein-free culture |
| AU709584B2 (en) * | 1995-08-01 | 1999-09-02 | Pasteur Merieux Serums Et Vaccins | Industrial production process for a vaccine against Japanese encephalitis, and vaccine obtained |
| FR2737412B1 (en) * | 1995-08-01 | 1997-10-24 | Pasteur Merieux Serums Vacc | PROCESS FOR PRODUCING A VACCINE AGAINST JAPANESE ENCEPHALITIS VIRUS AND VACCINE OBTAINED THEREBY |
| AU743546B2 (en) * | 1998-10-05 | 2002-01-31 | Research Foundation For Microbial Diseases Of Osaka University, The | Enhanced immunogen for inactivated vaccine for infection with Japanese encephalitis viruses and process for producing the same |
| AT409379B (en) | 1999-06-02 | 2002-07-25 | Baxter Ag | MEDIUM FOR PROTEIN- AND SERUM-FREE CELL CULTURE |
| US6855535B2 (en) * | 2001-12-10 | 2005-02-15 | Baxter Healthcare S.A. | Method of large scale production of Hepatitis A virus |
| US6951752B2 (en) | 2001-12-10 | 2005-10-04 | Bexter Healthcare S.A. | Method for large scale production of virus antigen |
| JP2007068401A (en) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | West nile virus vaccine |
| PT2235197T (en) * | 2007-12-27 | 2017-10-11 | Baxalta Inc | Cell culture processes |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT358167B (en) * | 1978-12-22 | 1980-08-25 | Immuno Ag | METHOD FOR PRODUCING EARLY SUMMER MENINGOENZEPHALITIS VIRUS (FSME VIRUS) VACCINES |
| SE445116B (en) * | 1979-09-12 | 1986-06-02 | Pharmacia Fine Chemicals Ab | MAKE CULTURE CELLS ON MICROBATORS WITH FIBRONECTINE LAYERS |
| NO161446C (en) * | 1981-03-13 | 1989-08-16 | Damon Biotech Inc | PROCEDURE FOR CULTING CELLS RELATED TO ANCHORING. |
| SE8103138L (en) * | 1981-05-19 | 1982-11-20 | Pharmacia Fine Chemicals Ab | MICROBATCHERS FOR CULTURE OF ANCHORING-DEPENDENT CELLS |
| CA1206900A (en) * | 1981-12-21 | 1986-07-02 | Raymond L. Downs | Hollow glass shell microcarrier for growth of cell cultures, and method of shell manufacture |
| AT385203B (en) * | 1985-04-26 | 1988-03-10 | Immuno Ag | METHOD FOR PRODUCING AN EARLY SUMMER MENINGOCEPHALITIS VIRUS (TBE VIRUS) VACCINE |
| DD274336A3 (en) * | 1985-10-03 | 1989-12-20 | Npo Biolar | Process for obtaining a microcarrier substance for cell cultivation |
-
1989
- 1989-12-22 AT AT2928/89A patent/AT393356B/en not_active IP Right Cessation
-
1990
- 1990-12-21 CA CA 2071954 patent/CA2071954C/en not_active Expired - Lifetime
- 1990-12-21 SK SK6590-90A patent/SK659090A3/en not_active IP Right Cessation
- 1990-12-21 JP JP50113291A patent/JP2633391B2/en not_active Expired - Fee Related
- 1990-12-21 WO PCT/AT1990/000128 patent/WO1991009935A1/en active IP Right Grant
- 1990-12-21 DK DK91900666T patent/DK0506714T3/en not_active Application Discontinuation
- 1990-12-21 HU HU9202009A patent/HU213886B/en unknown
- 1990-12-21 YU YU242390A patent/YU242390A/en unknown
- 1990-12-21 DE DE59007659T patent/DE59007659D1/en not_active Expired - Fee Related
- 1990-12-21 RU SU905052769A patent/RU2082757C1/en not_active IP Right Cessation
- 1990-12-21 CZ CS906590A patent/CZ281804B6/en not_active IP Right Cessation
- 1990-12-21 ES ES91900666T patent/ES2067916T3/en not_active Expired - Lifetime
- 1990-12-21 EP EP19910900666 patent/EP0506714B1/en not_active Expired - Lifetime
- 1990-12-21 AT AT91900666T patent/ATE113652T1/en not_active IP Right Cessation
-
1992
- 1992-06-18 FI FI922851A patent/FI98377C/en active
- 1992-06-19 NO NO19922422A patent/NO310305B1/en not_active IP Right Cessation
- 1992-11-25 HR HRP921354 patent/HRP921354A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HRP921354A2 (en) | 1996-02-29 |
| CZ281804B6 (en) | 1997-02-12 |
| HU213886B (en) | 1997-11-28 |
| NO922422D0 (en) | 1992-06-19 |
| FI922851A (en) | 1992-06-18 |
| SK279236B6 (en) | 1998-08-05 |
| EP0506714A1 (en) | 1992-10-07 |
| WO1991009935A1 (en) | 1991-07-11 |
| HUT65410A (en) | 1994-06-28 |
| JP2633391B2 (en) | 1997-07-23 |
| FI98377C (en) | 1997-06-10 |
| CZ659090A3 (en) | 1996-11-13 |
| DE59007659D1 (en) | 1994-12-08 |
| YU242390A (en) | 1993-05-28 |
| JPH05502581A (en) | 1993-05-13 |
| FI922851A0 (en) | 1992-06-18 |
| DK0506714T3 (en) | 1995-04-18 |
| HU9202009D0 (en) | 1992-10-28 |
| ATE113652T1 (en) | 1994-11-15 |
| CA2071954A1 (en) | 1991-06-23 |
| SK659090A3 (en) | 1998-08-05 |
| FI98377B (en) | 1997-02-28 |
| EP0506714B1 (en) | 1994-11-02 |
| RU2082757C1 (en) | 1997-06-27 |
| CA2071954C (en) | 1996-06-18 |
| ES2067916T3 (en) | 1995-04-01 |
| NO310305B1 (en) | 2001-06-18 |
| ATA292889A (en) | 1991-03-15 |
| AT393356B (en) | 1991-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1019233A1 (en) | Animal cells and processes for the replication of influenza viruses | |
| SE8000243L (en) | TYPE II INTERFERON AND AGENTS CONTAINING THE SAME | |
| FI930206A0 (en) | ADOPTIV IMMUNOTHERAPY MED INTERLEUKIN-7 | |
| ATE2014T1 (en) | LIVE, ATTENDED HEPATITIS A VIRUS IN HUMAN, PROCESS FOR ITS CULTIVATION IN CELL CULTURE IN VITRO AND COMPOSITION CONTAINING THIS VIRUS. | |
| DK0414475T3 (en) | Methods for culturing HCV in B or T lymphocyte cell lines | |
| BR8405600A (en) | PROCESS TO ESTABLISH A GROWTH CULTURE IN A VASE, SEALED VASE, SET TO PREPARE A MICROORGANISM GROWTH CULTURE AND PROCESS TO FREEZE MICROORGANISMS AND NUTRIENT DRYING AND TO ESTABLISH A GROWTH CULTURE | |
| NO922422L (en) | MATERIAL WITH ADHERENT BONDED CELLS, AND PROCEDURES FOR PRODUCING VIRUS / VIRUS ANTIGENS | |
| DE69626022D1 (en) | METHOD FOR THE INDUSTRIAL PRODUCTION OF A JAPANESE ENKEPHALITIS VACCINE, AND Vaccine Obtained In This Way | |
| AU554080B2 (en) | Production of viral antisens | |
| ES8104405A1 (en) | Influenza virus vaccines, process for preparing them and process for propagating influenza viruses. | |
| HUP0101081A2 (en) | Medium and method for viral propagation and growth | |
| IE47060B1 (en) | Process for the cultivation of viruses | |
| KR930018034A (en) | Preparation method of trehalose | |
| AU6262786A (en) | Growing aids virus in cell lines lacking human class ii histocompatability antigens | |
| CA2250714A1 (en) | Animal cells and processes for the replication of influenza viruses | |
| KR870009018A (en) | Wax for Herpes Simplex | |
| UA21969A1 (en) | A process for preparation of inactivated cultural vaccine against aueski disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |